HealthStream (NASDAQ:HSTM) Director Sells $174,000.00 in Stock

HealthStream, Inc. (NASDAQ:HSTM) Director Linda Rebrovick sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $29.00, for a total value of $174,000.00. Following the completion of the sale, the director directly owned 51,329 shares of the company’s stock, valued at $1,488,541. This represents a 10.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Linda Rebrovick also recently made the following trade(s):

• On Monday, June 1st, Linda Rebrovick sold 2,000 shares of HealthStream stock. The stock was sold at an average price of $25.00, for a total transaction of $50,000.00.

HealthStream Trading Down 0.6%

HSTM stock opened at $28.02 on Friday. The company’s 50-day moving average price is $25.23 and its 200 day moving average price is $22.75. The company has a market cap of $818.74 million, a P/E ratio of 41.82, a P/E/G ratio of 3.19 and a beta of 0.45. HealthStream, Inc. has a 52 week low of $19.50 and a 52 week high of $30.00.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, May 4th. The technology company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The business had revenue of $81.20 million for the quarter, compared to analysts’ expectations of $79.68 million. HealthStream had a return on equity of 6.47% and a net margin of 6.39%. On average, equities research analysts expect that HealthStream, Inc. will post 0.74 earnings per share for the current year.

HealthStream Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Monday, May 18th were issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, May 18th. HealthStream’s dividend payout ratio is 20.90%.

HealthStream announced that its board has approved a stock repurchase plan on Friday, March 13th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the technology company to purchase up to 1.7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Copeland Capital Management LLC increased its holdings in shares of HealthStream by 43.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after acquiring an additional 389,186 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of HealthStream by 302.0% in the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after purchasing an additional 186,231 shares in the last quarter. Lazard Asset Management LLC increased its stake in HealthStream by 268.2% during the 1st quarter. Lazard Asset Management LLC now owns 157,208 shares of the technology company’s stock valued at $3,256,000 after buying an additional 114,511 shares during the period. Qube Research & Technologies Ltd increased its stake in shares of HealthStream by 77.3% during the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after acquiring an additional 109,883 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of HealthStream by 6.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares during the period. 69.58% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Canaccord Genuity Group boosted their price target on HealthStream to $24.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, HealthStream has an average rating of “Hold” and an average target price of $24.00.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.